Altimmune (ALT) - Get Report shares fell sharply after the biopharmaceutical company announced the Food and Drug Administration put a clinical hold on its Investigational new drug application for AdCOVID, a single-dose intranasal Covid-19 vaccine candidate.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,